Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Syndax Pharmaceuticals (SNDX) Non Operating Income (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has 6 years of Non Operating Income data on record, last reported at $953000.0 in Q4 2020.

  • For Q4 2020, Non Operating Income rose 169.77% year-over-year to $953000.0; the TTM value through Dec 2020 reached -$219000.0, down 177.22%, while the annual FY2025 figure was -$12.3 million, 4895.14% down from the prior year.
  • Non Operating Income reached $953000.0 in Q4 2020 per SNDX's latest filing, up from -$584000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $953000.0 in Q4 2020 and bottomed at -$1.6 million in Q1 2016.
  • Average Non Operating Income over 5 years is $6050.0, with a median of $298000.0 recorded in 2016.
  • The widest YoY moves for Non Operating Income: up 177.34% in 2018, down 475.58% in 2018.
  • A 5-year view of Non Operating Income shows it stood at $326000.0 in 2016, then grew by 18.1% to $385000.0 in 2017, then tumbled by 475.58% to -$1.4 million in 2018, then increased by 5.53% to -$1.4 million in 2019, then surged by 169.77% to $953000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $953000.0 in Q4 2020, -$584000.0 in Q3 2020, and -$452000.0 in Q2 2020.